Sort
15,842 grants matching “pancreatic cancer”
Synergistic targeting of cholesterol metabolism and EGFR signaling in cancer
$370,388Igor Astsaturov · Research Inst Of Fox Chase Can Ctr · R01 · FY2014 · CA
Synergistic targeting of cholesterol metabolism and EGFR signaling in cancer
$370,388Igor Astsaturov · Research Inst Of Fox Chase Can Ctr · R01 · FY2016 · CA
Targeting metabolic stress to induce pancreatic tumor cell death
$370,329Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Rapid unbiased isolation and in situ RNA analysis of circulating tumor cells using a magnetic micropore-based diagnostic chip
$370,163David Aaron Issadore · University Of Pennsylvania · R33 · FY2019 · CA
Multi-Excitation TIRF Microscope for Shared Resource
$370,045K. Sam Wells · Vanderbilt University · S10 · FY2015 · OD
TBEL Project 1
$370,013Marina Pasca Di Magliano · University Of Tx Md Anderson Can Ctr · U54 · FY2022 · CA
Mechanisms of cancer cell chemotaxis in perineural invasion
$370,007Richard J Wong · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
Project 1: Targeting Metabolic Dependencies in PDAC
$369,941Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2018 · CA
Comprehensive genetic dissection of druggable KRAS targets
$369,932Steven D Leach · Dartmouth College · R01 · FY2019 · CA
A novel T cell subset with increased potency and persistence for the treatment of solid tumors
$369,916Brian Newsom · Ares Immunotherapy, Inc. · R43 · FY2021 · CA
The role of entosis in human cancers
$369,905Michael H. Overholtzer · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Rewiring the myeloid cell response to adjuvants to improve tumor control
$369,889Michael James Gough · Providence Portland Medical Center · R01 · FY2023 · CA
Rewiring the myeloid cell response to adjuvants to improve tumor control
$369,889Michael James Gough · Providence Portland Medical Center · R01 · FY2022 · CA
Mechanistic dissection and inhibitor targeting of autophagy in RAS driven cancers
$369,832Kirsten L Bryant · Univ Of North Carolina Chapel Hill · R37 · FY2020 · CA
On the path to the clinic: Lead optimization and pathway analysis of the pancreatic cancer-selective drug conjugate SW V-49
$369,812William G Hawkins · Washington University · R01 · FY2019 · CA
The RAS and P13K Pathways in Pancreatic Adenocarcinoma
$369,799Lewis C Cantley · Dana-Farber Cancer Inst · P01 · FY2008 · CA
Keratins as novel determinants of tumor biology
$369,781Pierre Coulombe · Johns Hopkins University · R01 · FY2014 · CA
Mechanisms of diabetic amyloid formation studied with 2D IR spectroscopy
$369,780Martin T Zanni · University Of Wisconsin-Madison · R01 · FY2016 · DK
Mechanisms of diabetic amyloid formation studied with 2D IR spectroscopy
$369,780Martin T Zanni · University Of Wisconsin-Madison · R01 · FY2018 · DK
CPML - Project 3: Genome-wide Studies of Adverse Effects
$369,780Mary V. Relling · St. Jude Children'S Research Hospital · P50 · FY2017 · GM
Mechanisms of diabetic amyloid formation studied with 2D IR spectroscopy
$369,780Martin T Zanni · University Of Wisconsin-Madison · R01 · FY2019 · DK
Mechanisms of diabetic amyloid formation studied with 2D IR spectroscopy
$369,780Martin T Zanni · University Of Wisconsin-Madison · R01 · FY2017 · DK
Spread of Replicating Adenovirus in Pancreatic Tumors
$369,617New York University School Of Medicine · R01 · FY2003 · CA
Combining Machine Learning and Nanofluidic Technology for The Multiplexed Diagnosis of Pancreatic Adenocarcinoma
$369,607David Aaron Issadore · University Of Pennsylvania · R33 · FY2024 · CA
MECHANISMS OF INTESTINAL TUMORIGENESIS
$369,596Emory University · R01 · FY2004 · CA